Answer
Zanamivir (Relenza) should preferably be avoided during pregnancy unless the woman's clinical condition means the potential maternal benefit significantly outweighs the possible fetal risk.
Sources for this answer
- Relenza 5mg/dose inhalation powder.GlaxoSmithKline UK · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 26Document updated
Sources checked